Lung Cancer Screening Software Market - Forecast(2024 - 2030)

Report Code: HCR 14960 Report Format: PDF + Excel

Lung Cancer Screening Software Market Overview

Lung Cancer Screening Software Market size is estimated to reach $45.3 million by 2026, growing at a CAGR of 19.5% during the forecast period 2021-2026. Lung cancer screening is a process of detecting lung cancer with the usage of different technologies and software solutions. Lung cancer screening software helps in the management of patient’s participation in lung screening programs and also provides an efficient way for healthcare professionals to collect, curate, and transfer data to patients. This software also enables to identify cancer patients at risk and automates the flow of data with integrated electronic health records. Increase in the awareness about screening programs, growing number of studies and clinical trials for evaluating the effectiveness of cancer screening software, rise in the demand for screening with chest radiography and low dose computed tomography, and increase in the demand for cloud-based solutions are the factors that are set to drive the growth of the Lung Cancer Screening Software Market for the period 2021-2026.

Lung Cancer Screening Software Market Report Coverage

The report: “Lung Cancer Screening Software Market Forecast (2021-2026)”, by Industry ARC, covers an in-depth analysis of the following segments of the Lung Cancer Screening Software Market.

By Mode of Delivery: Cloud based Solutions, On-premise Solutions, and Web based Solutions.
By Application: Non-small Cell Lung Cancer and Small Cell Lung Cancer.
By End User: Hospitals, Oncology Centers, Ambulatory Surgical Centers, and Others.
By Geography: North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, Russia, and Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Australia & New Zealand, and Rest of Asia-Pacific), South America (Brazil, Argentina, and Rest of South America) and Rest of World (Middle East and Africa).

Key Takeaways

  • Geographically, the North America Lung Cancer Screening Software Market is accounted for the highest revenue share in 2020 and it is poised to dominate over the period 2021-2026 owing to the rise in the demand for screening with chest radiography.
  • The increase in the demand for innovative technologies in the treatment of non-small cell lung cancer is driving the growth of the Non-small Cell Lung Cancer segment.
  • Lack of skilled medical personnel is one of the major factors that is said to reduce the growth of the Lung Cancer Screening Software Market.
  • Detailed analysis on the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Lung Cancer Screening Software Market report.

Lung Cancer Screening Software Market Segment Analysis-By Mode of Delivery

The Lung Cancer Screening Software Market based on the Mode of Delivery can be further segmented into Cloud based Solutions, On-premise Solutions, and Web based Solutions. The Cloud based Solutions segment held the largest share in 2020 and is also estimated to be the fastest growing segment with a CAGR of 20.3% over the period 2021-2026. This growth is owing to the increasing need for less infrastructure across the world. Cloud-based solutions offer greater security through leveraging industry-leading security standards, large encrypted server environments, and also provides greater access control within the cloud for minimizing information leaks, which is driving the growth of the Lung Cancer Screening Software Market. The Web based solutions segment held the second largest share in 2020 owing to the factors such as lower development costs, easy data sharing and collaboration, and easy installation and maintenance.

Lung Cancer Screening Software Market, By Mode of Delivery, 2020(%)

Lung Cancer Screening Software Market Segment Analysis - By Application

The Lung Cancer Screening Software Market based on the Application can be further segmented into Non-small Cell Lung Cancer and Small Cell Lung Cancer. The Non-small Cell Lung Cancer segment held the largest share in 2020 and is also estimated to be the fastest growing segment with a CAGR of 19.8% over the period 2021-2026. This growth is owing to the growing incidence of non-small cell lung cancer (SCLC) in the developed nations and rise in the demand for screening with chest radiography in the treatment of non-small cell lung cancer. The increase in the demand for innovative technologies in the treatment of non-small cell lung cancer is driving the growth of the Lung Cancer Screening Software Market. The Small Cell Lung Cancer segment held the second largest share in 2020 owing to the factors such as increase in longstanding tobacco smoking among the young population and growing exposure to secondhand smoke.

Lung Cancer Screening Software Market Segment Analysis - By Geography

North America held the largest share with 31% of the overall market in 2020. The growth in this segment is owing to the factors such as increase in the number of screening programs, growing adoption of software solutions for patient management, rise in the demand for screening with chest radiography, and the presence of large number of screening centers. The increase in the number of studies and clinical trials for evaluating the effectiveness of cancer screening software is driving the growth of the Lung Cancer Screening Software Market. Asia-Pacific is estimated to be the fastest growing segment over the period 2021-2026. The growth in this segment is owing to the increase in the awareness about screening programs, growing focus on improving healthcare infrastructure, and rise in the demand for screening with low dose computed tomography.

Lung Cancer Screening Software Market Drivers

Rise in the Demand for Cloud based Solutions

Cloud based Solutions allow oncology centers to leverage a network of remotely accessible servers where they can store large volumes of data in a secure environment. Cloud-based solutions have made it easier for oncologists to collaboratively share a patient’s medical records. Health care organizations are increasingly adopting cloud-based solutions as a means of storing and protecting patients, which is driving the growth of the Lung Cancer Screening Software Market.

Increase in the Awareness about the Effectiveness of Lung Cancer Screening Programs

There is a rapid increase in the awareness about lung cancer screening programs owing to the effectiveness in the treatment of lung cancer. A number of clinical trials and demonstration projects are also being conducted across the globe to evaluate the effectiveness of lung cancer screening with chest radiography and low dose computed tomography, which is driving the growth of the market. Favorable government initiatives for successful implementation of screening programs are further propelling the growth of the market.

Lung Cancer Screening Software Market Challenges

Lack of Skilled Medical Personnel

The Lung cancer screening software helps in the management of patient’s participation in lung screening programs and also provides an efficient way for healthcare professionals to collect and transfer data to clinicians and patients. However, the lack of technically skilled professionals for cancer diagnosis is one of the major factors that is estimated to reduce the growth of the market.

Lung Cancer Screening Software Market Landscape

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Lung Cancer Screening Software Market. Key companies of this market are Koninklijke Philips, Siemens Healthineers AG, MRS Systems Inc, Magview, PenRad Technologies Inc, Eon Health, Nuance Communications, ProVation Medical Inc, HealthMyne, Optellum Ltd among others.

Acquisitions/Product Launches:

  • In November 2020, Eon Health has launched Centralized Management, the only market available patient management service to fully manage every aspect of a lung cancer screening and incidental pulmonary nodule program to reduce time-consuming tasks utilizing automated technology and allow care teams to focus solely on patient care and revenue-boosting efforts.
  • In September 2020, Koninklijke Philips has launched Azurion Lung Edition imaging system software, which is a 3D-imaging and navigation software for treating lung cancer and to support image-guided lung procedures.
  • In July 2020, Optellum Ltd has partnered with the University of Oxford in the Artificial Intelligence Program to deliver clinical decision support software for physicians in selecting optimal and treatment procedures for lung cancer.

Relevant Reports

Report Code: HCR 0078

Report Code: HCR 90545

For more Lifesciences and Healthcare Market reports, please click here

1. Lung Cancer Screening Software Market - Overview
    1.1 Definitions and Scope
2. Lung Cancer Screening Software Market - Executive Summary
    2.1 Market Revenue and Key Trends by Company
    2.2 Key trends by Mode of Delivery
    2.3 Key trends by Application
    2.4 Key trends by Geography
3. Lung Cancer Screening Software Market – Comparative Analysis
    3.1 Product Benchmarking – Key Companies
    3.2 Financial Analysis – Key Companies
    3.3 Market Value Split by Key Companies
    3.4 Patent Analysis – Key Companies
    3.5 Pricing Analysis
4. Lung Cancer Screening Software Market - Startup Companies Scenario Premium
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. Lung Cancer Screening Software Market – Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Lung Cancer Screening Software Market Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes
7. Lung Cancer Screening Software Market – Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Lung Cancer Screening Software Market – By Mode of Delivery(Market Size –$Million/$Billion)
    8.1 Cloud based Solutions
    8.2 On-premise Solutions
    8.3 Web based Solutions
9. Lung Cancer Screening Software Market – By Application(Market Size –$Million/$Billion)
    9.1 Non-small Cell Lung Cancer
    9.2 Small Cell Lung Cancer
10. Lung Cancer Screening Software Market – By End User (Market Size –$Million/$Billion)
    10.1 Hospitals
    10.2 Oncology Centers
    10.3 Ambulatory Surgical Centers
    10.4 Others
11. Lung Cancer Screening Software Market - By Geography (Market Size –$Million/$Billion)
    11.1 North America
        11.1.1 U.S.
        11.1.2 Mexico
        11.1.3 Canada
    11.2 Europe
        11.2.1 U.K.
        11.2.2 France
        11.2.3 Germany
        11.2.4 Italy
        11.2.5 Spain
        11.2.6 Russia
        11.2.7 Rest of Europe
    11.3 Asia Pacific
        11.3.1 China
        11.3.2 India
        11.3.3 Japan
        11.3.4 South Korea
        11.3.5 Australia & New Zealand
        11.3.6 Rest of APAC
    11.4 Rest of the World
        11.4.1 Middle East
        11.4.2 Africa
        11.4.3 South America
12. Lung Cancer Screening Software Market - Entropy
13. Lung Cancer Screening Software Market – Industry/Segment Competition Landscape Premium
    13.1 Market Share Analysis
        13.1.1 Global Market Share – Key Companies
        13.1.2 Market Share by Region – Key companies
        13.1.3 Market Share by Countries – Key Companies
        13.1.4 Best Practices for Companies
14. Lung Cancer Screening Software Market – Key Company List by Country Premium Premium
15. Lung Cancer Screening Software Market Company Analysis
    15.1 Company 1
    15.2 Company 2
    15.3 Company 3
    15.4 Company 4
    15.5 Company 5
    15.6 Company 6
    15.7 Company 7
    15.8 Company 8
    15.9 Company 9
    15.10 Company 10
"*Financials for private companies would be provided on a best efforts basis”.

LIST OF TABLES

1.Global Lung Cancer Screening Software Market:Competitive Analysis Market 2023-2030 ($M)
1.1 Company/Competition Categorization Market 2023-2030 ($M) - Global Industry Research
1.1.1 List of key end-users Market 2023-2030 ($M)
1.1.2 Company market share analysis Market 2023-2030 ($M)
2.Global Competitive Landscape Market 2023-2030 ($M)
2.1 Nuance Communications, Inc. Market 2023-2030 ($M) - Global Industry Research
2.2 Eon Market 2023-2030 ($M) - Global Industry Research
2.3 Koninklijke Philips N.V. Market 2023-2030 ($M) - Global Industry Research
2.4 Siemens Healthineers AG Market 2023-2030 ($M) - Global Industry Research
2.5 PenRad Technologies, Inc. Market 2023-2030 ($M) - Global Industry Research
2.6 MRS Systems, Inc. Market 2023-2030 ($M) - Global Industry Research
2.7 Magview Market 2023-2030 ($M) - Global Industry Research
3.Global Lung Cancer Screening Software Market:Competitive Analysis Market 2023-2030 (Volume/Units)
3.1 Company/Competition Categorization Market 2023-2030 (Volume/Units) - Global Industry Research
3.1.1 List of key end-users Market 2023-2030 (Volume/Units)
3.1.2 Company market share analysis Market 2023-2030 (Volume/Units)
4.Global Competitive Landscape Market 2023-2030 (Volume/Units)
4.1 Nuance Communications, Inc. Market 2023-2030 (Volume/Units) - Global Industry Research
4.2 Eon Market 2023-2030 (Volume/Units) - Global Industry Research
4.3 Koninklijke Philips N.V. Market 2023-2030 (Volume/Units) - Global Industry Research
4.4 Siemens Healthineers AG Market 2023-2030 (Volume/Units) - Global Industry Research
4.5 PenRad Technologies, Inc. Market 2023-2030 (Volume/Units) - Global Industry Research
4.6 MRS Systems, Inc. Market 2023-2030 (Volume/Units) - Global Industry Research
4.7 Magview Market 2023-2030 (Volume/Units) - Global Industry Research
5.North America Lung Cancer Screening Software Market:Competitive Analysis Market 2023-2030 ($M)
5.1 Company/Competition Categorization Market 2023-2030 ($M) - Regional Industry Research
5.1.1 List of key end-users Market 2023-2030 ($M)
5.1.2 Company market share analysis Market 2023-2030 ($M)
6.North America Competitive Landscape Market 2023-2030 ($M)
6.1 Nuance Communications, Inc. Market 2023-2030 ($M) - Regional Industry Research
6.2 Eon Market 2023-2030 ($M) - Regional Industry Research
6.3 Koninklijke Philips N.V. Market 2023-2030 ($M) - Regional Industry Research
6.4 Siemens Healthineers AG Market 2023-2030 ($M) - Regional Industry Research
6.5 PenRad Technologies, Inc. Market 2023-2030 ($M) - Regional Industry Research
6.6 MRS Systems, Inc. Market 2023-2030 ($M) - Regional Industry Research
6.7 Magview Market 2023-2030 ($M) - Regional Industry Research
7.South America Lung Cancer Screening Software Market:Competitive Analysis Market 2023-2030 ($M)
7.1 Company/Competition Categorization Market 2023-2030 ($M) - Regional Industry Research
7.1.1 List of key end-users Market 2023-2030 ($M)
7.1.2 Company market share analysis Market 2023-2030 ($M)
8.South America Competitive Landscape Market 2023-2030 ($M)
8.1 Nuance Communications, Inc. Market 2023-2030 ($M) - Regional Industry Research
8.2 Eon Market 2023-2030 ($M) - Regional Industry Research
8.3 Koninklijke Philips N.V. Market 2023-2030 ($M) - Regional Industry Research
8.4 Siemens Healthineers AG Market 2023-2030 ($M) - Regional Industry Research
8.5 PenRad Technologies, Inc. Market 2023-2030 ($M) - Regional Industry Research
8.6 MRS Systems, Inc. Market 2023-2030 ($M) - Regional Industry Research
8.7 Magview Market 2023-2030 ($M) - Regional Industry Research
9.Europe Lung Cancer Screening Software Market:Competitive Analysis Market 2023-2030 ($M)
9.1 Company/Competition Categorization Market 2023-2030 ($M) - Regional Industry Research
9.1.1 List of key end-users Market 2023-2030 ($M)
9.1.2 Company market share analysis Market 2023-2030 ($M)
10.Europe Competitive Landscape Market 2023-2030 ($M)
10.1 Nuance Communications, Inc. Market 2023-2030 ($M) - Regional Industry Research
10.2 Eon Market 2023-2030 ($M) - Regional Industry Research
10.3 Koninklijke Philips N.V. Market 2023-2030 ($M) - Regional Industry Research
10.4 Siemens Healthineers AG Market 2023-2030 ($M) - Regional Industry Research
10.5 PenRad Technologies, Inc. Market 2023-2030 ($M) - Regional Industry Research
10.6 MRS Systems, Inc. Market 2023-2030 ($M) - Regional Industry Research
10.7 Magview Market 2023-2030 ($M) - Regional Industry Research
11.APAC Lung Cancer Screening Software Market:Competitive Analysis Market 2023-2030 ($M)
11.1 Company/Competition Categorization Market 2023-2030 ($M) - Regional Industry Research
11.1.1 List of key end-users Market 2023-2030 ($M)
11.1.2 Company market share analysis Market 2023-2030 ($M)
12.APAC Competitive Landscape Market 2023-2030 ($M)
12.1 Nuance Communications, Inc. Market 2023-2030 ($M) - Regional Industry Research
12.2 Eon Market 2023-2030 ($M) - Regional Industry Research
12.3 Koninklijke Philips N.V. Market 2023-2030 ($M) - Regional Industry Research
12.4 Siemens Healthineers AG Market 2023-2030 ($M) - Regional Industry Research
12.5 PenRad Technologies, Inc. Market 2023-2030 ($M) - Regional Industry Research
12.6 MRS Systems, Inc. Market 2023-2030 ($M) - Regional Industry Research
12.7 Magview Market 2023-2030 ($M) - Regional Industry Research
13.MENA Lung Cancer Screening Software Market:Competitive Analysis Market 2023-2030 ($M)
13.1 Company/Competition Categorization Market 2023-2030 ($M) - Regional Industry Research
13.1.1 List of key end-users Market 2023-2030 ($M)
13.1.2 Company market share analysis Market 2023-2030 ($M)
14.MENA Competitive Landscape Market 2023-2030 ($M)
14.1 Nuance Communications, Inc. Market 2023-2030 ($M) - Regional Industry Research
14.2 Eon Market 2023-2030 ($M) - Regional Industry Research
14.3 Koninklijke Philips N.V. Market 2023-2030 ($M) - Regional Industry Research
14.4 Siemens Healthineers AG Market 2023-2030 ($M) - Regional Industry Research
14.5 PenRad Technologies, Inc. Market 2023-2030 ($M) - Regional Industry Research
14.6 MRS Systems, Inc. Market 2023-2030 ($M) - Regional Industry Research
14.7 Magview Market 2023-2030 ($M) - Regional Industry Research

LIST OF FIGURES

1.US Lung Cancer Screening Software Market Revenue, 2023-2030 ($M)
2.Canada Lung Cancer Screening Software Market Revenue, 2023-2030 ($M)
3.Mexico Lung Cancer Screening Software Market Revenue, 2023-2030 ($M)
4.Brazil Lung Cancer Screening Software Market Revenue, 2023-2030 ($M)
5.Argentina Lung Cancer Screening Software Market Revenue, 2023-2030 ($M)
6.Peru Lung Cancer Screening Software Market Revenue, 2023-2030 ($M)
7.Colombia Lung Cancer Screening Software Market Revenue, 2023-2030 ($M)
8.Chile Lung Cancer Screening Software Market Revenue, 2023-2030 ($M)
9.Rest of South America Lung Cancer Screening Software Market Revenue, 2023-2030 ($M)
10.UK Lung Cancer Screening Software Market Revenue, 2023-2030 ($M)
11.Germany Lung Cancer Screening Software Market Revenue, 2023-2030 ($M)
12.France Lung Cancer Screening Software Market Revenue, 2023-2030 ($M)
13.Italy Lung Cancer Screening Software Market Revenue, 2023-2030 ($M)
14.Spain Lung Cancer Screening Software Market Revenue, 2023-2030 ($M)
15.Rest of Europe Lung Cancer Screening Software Market Revenue, 2023-2030 ($M)
16.China Lung Cancer Screening Software Market Revenue, 2023-2030 ($M)
17.India Lung Cancer Screening Software Market Revenue, 2023-2030 ($M)
18.Japan Lung Cancer Screening Software Market Revenue, 2023-2030 ($M)
19.South Korea Lung Cancer Screening Software Market Revenue, 2023-2030 ($M)
20.South Africa Lung Cancer Screening Software Market Revenue, 2023-2030 ($M)
21.North America Lung Cancer Screening Software By Application
22.South America Lung Cancer Screening Software By Application
23.Europe Lung Cancer Screening Software By Application
24.APAC Lung Cancer Screening Software By Application
25.MENA Lung Cancer Screening Software By Application